Reem I. Alsantali
Reem I. Alsantali publishes mostly in Organic Chemistry, Materials Chemistry and Molecular Biology, on topics such as Synthesis and biological activity, Adsorption and biosorption for pollutant removal and Click Chemistry and Applications.
- World rank
- #568,936 of 7,710,434 ranked researchers
- Rank in Saudi Arabia
- #2,359 of 25,688
- Works
- 67
- Citations
- 1.8k
- Citations per work
- 26.5
What does Reem I. Alsantali research?
Reem I. Alsantali's work is mostly in Chemistry (29%), Materials Science (8%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences3045.4%
- Chemistry2029.2%
- Materials Science58.1%
- Environmental Science34.9%
- Energy23.2%
- Everything else2943.8%
- Life Sciences57.0%
- Health Sciences33.8%
- Medicine33.8%
- 1Organic Chemistry29% of their works
- 2Materials Chemistry8% of their works
- 3Molecular Biology7% of their works
- 4Water Science and Technology5% of their works
- 5Pharmacology4% of their works
- 6Renewable Energy, Sustainability and the Environment3% of their works
Research topics
- Synthesis and biological activity
- Adsorption and biosorption for pollutant removal
- Click Chemistry and Applications
- melanin and skin pigmentation
- Bioactive Compounds and Antitumor Agents
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Multicomponent Synthesis of Heterocycles
Which keywords describe Reem I. Alsantali's research?
The keywords of their largest research topics: Anticancer Agents, Heterocyclic Compounds, Medicinal Chemistry, Drug Discovery, Tubulin Inhibitors, Vascular Targeting Agents, Adsorption and Antimicrobial Activity.
- Toxicology
- Quinones
- Green Chemistry
- Antimicrobial
- Melanin
- Click Chemistry
- Contaminant Removal
- Antimicrobial Activity
- Vascular Targeting Agents
- Drug Discovery
- Heterocyclic Compounds
- Anticancer Agents
- Medicinal Chemistry
- Tubulin Inhibitors
- Adsorption
- Biological Evaluation
- Synthesis
- Copper-Catalyzed Cycloaddition
- Pigmentation
- Derivatives
- Multicomponent Reactions
- Quinoxaline
- Triazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Anticancer Agents213 topics
- Heterocyclic Compounds172 topics
- Medicinal Chemistry172 topics
- Drug Discovery153 topics
- Tubulin Inhibitors131 topic
- Vascular Targeting Agents131 topic
- Adsorption81 topic
- Antimicrobial Activity82 topics
- Biological Evaluation82 topics
- Contaminant Removal81 topic
- Synthesis82 topics
- Click Chemistry71 topic
- Copper-Catalyzed Cycloaddition71 topic
- Melanin51 topic
- Pigmentation51 topic
- Antimicrobial41 topic
- Derivatives41 topic
- Green Chemistry41 topic
- Multicomponent Reactions41 topic
- Quinones41 topic
- Quinoxaline41 topic
- Toxicology41 topic
- Triazines41 topic
Where does Reem I. Alsantali work?
Reem I. Alsantali's main affiliation in the publication record is Taif University, Saudi Arabia.
How many publications and citations does Reem I. Alsantali have?
OpenAlex counts 67 works and 1,773 citations for Reem I. Alsantali, an h-index of 23, ranking #568,936 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Reem I. Alsantali. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.